OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PROTACs targeting androgen receptor signaling: Potential therapeutic agents for castration-resistant prostate cancer
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 8
Yulu Zhang, Annan Ming, Junyan Wang, et al.
Pharmacological Research (2024) Vol. 205, pp. 107234-107234
Open Access | Times Cited: 8
Showing 8 citing articles:
A protracted war against cancer drug resistance
Yuan Tian, Xiaowei Wang, Cong Wu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Yuan Tian, Xiaowei Wang, Cong Wu, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects
Lei Tang, Xin Chen, Jianquan Hou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Lei Tang, Xin Chen, Jianquan Hou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Recent advances in PROTAC-based antiviral and antibacterial therapeutics
Can Zhou, Shiwei Yang, Jun Wang, et al.
Bioorganic Chemistry (2025), pp. 108437-108437
Closed Access
Can Zhou, Shiwei Yang, Jun Wang, et al.
Bioorganic Chemistry (2025), pp. 108437-108437
Closed Access
Periprostatic adipose tissue inhibits tumor progression by secreting apoptotic factors: A natural barrier induced by the immune response during the early stages of prostate cancer
I‐Hung Shao, Tzu-Hsuan Chang, Ying‐Hsu Chang, et al.
Oncology Letters (2024) Vol. 28, Iss. 4
Open Access | Times Cited: 1
I‐Hung Shao, Tzu-Hsuan Chang, Ying‐Hsu Chang, et al.
Oncology Letters (2024) Vol. 28, Iss. 4
Open Access | Times Cited: 1
Identification of circadian clock-related immunological prognostic index and molecular subtypes in prostate cancer
Lu Che, Dengxiong Li, Jie Wang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Lu Che, Dengxiong Li, Jie Wang, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Research progress of BRD4 in head and neck squamous cell carcinoma: Therapeutic application of novel strategies and mechanisms
Jiao Tang, Huaqiu Chen, Hengrui Fan, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117929-117929
Closed Access
Jiao Tang, Huaqiu Chen, Hengrui Fan, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 113, pp. 117929-117929
Closed Access
Design, synthesis and biological evaluation of dual inhibitors targeting AR/AR-Vs and PARP1 in castration resistant prostate cancer therapy
Si-Han Zhang, Yaowu Su, Mengzhu Zheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117485-117485
Open Access
Si-Han Zhang, Yaowu Su, Mengzhu Zheng, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117485-117485
Open Access
Recent Advances in Developing Targeted Protein Degraders
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117212-117212
Closed Access
Binbin Cheng, Hongqiao Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2024) Vol. 284, pp. 117212-117212
Closed Access
